OPNT Annual Operating Profit
$5.16 M
+$7.40 M+330.09%
31 December 2021
Summary:
As of January 24, 2025, OPNT annual operaing income is $5.16 million, with the most recent change of +$7.40 million (+330.09%) on December 31, 2021. During the last 3 years, it has risen by +$26.35 million (+124.33%).OPNT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Quarterly Operating Profit
-$9.63 M
+$1.74 M+15.27%
30 September 2022
Summary:
As of January 24, 2025, OPNT quarterly operating income is -$9.63 million, with the most recent change of +$1.74 million (+15.27%) on September 30, 2022. Over the past year, it has dropped by -$13.59 million (-343.15%).OPNT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT TTM Operating Profit
-$31.51 M
-$13.59 M-75.84%
30 September 2022
Summary:
As of January 24, 2025, OPNT TTM operating income is -$31.51 million, with the most recent change of -$13.59 million (-75.84%) on September 30, 2022. Over the past year, it has dropped by -$34.38 million (-1198.72%).OPNT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +330.1% | -343.1% | -1198.7% |
| 3 y3 years | +124.3% | -190.9% | -388.8% |
| 5 y5 years | +234.4% | -71.8% | -388.8% |
OPNT Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -52.7% | -190.5% | -386.0% |
Opiant Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$9.63 M(-15.3%) | -$31.51 M(+75.8%) |
| June 2022 | - | -$11.37 M(-3.6%) | -$17.92 M(+316.0%) |
| Mar 2022 | - | -$11.79 M(-1025.3%) | -$4.31 M(-183.5%) |
| Dec 2021 | $5.16 M(-330.1%) | $1.27 M(-67.8%) | $5.16 M(+79.8%) |
| Sept 2021 | - | $3.96 M(+76.3%) | $2.87 M(-884.8%) |
| June 2021 | - | $2.25 M(-196.6%) | -$365.40 K(-87.1%) |
| Mar 2021 | - | -$2.32 M(+129.2%) | -$2.84 M(+26.9%) |
| Dec 2020 | -$2.24 M(-120.5%) | -$1.01 M(-239.5%) | -$2.24 M(+355.3%) |
| Sept 2020 | - | $727.20 K(-414.0%) | -$492.20 K(-105.2%) |
| June 2020 | - | -$231.60 K(-86.6%) | $9.38 M(-14.9%) |
| Mar 2020 | - | -$1.72 M(-334.5%) | $11.02 M(+1.0%) |
| Dec 2019 | $10.91 M(-151.5%) | $734.40 K(-93.1%) | $10.91 M(+1860.7%) |
| Sept 2019 | - | $10.60 M(+651.7%) | $556.50 K(-105.1%) |
| June 2019 | - | $1.41 M(-177.1%) | -$10.98 M(-19.9%) |
| Mar 2019 | - | -$1.83 M(-81.0%) | -$13.71 M(-35.3%) |
| Dec 2018 | -$21.19 M(-1474.2%) | -$9.62 M(+923.4%) | -$21.19 M(+83.1%) |
| Sept 2018 | - | -$940.00 K(-28.9%) | -$11.57 M(-28.7%) |
| June 2018 | - | -$1.32 M(-85.8%) | -$16.24 M(+10.3%) |
| Mar 2018 | - | -$9.31 M(+66.0%) | -$14.71 M(-812.3%) |
| Dec 2017 | $1.54 M(-78.3%) | - | - |
| Oct 2017 | - | -$5.61 M(-2911.4%) | $2.07 M(-70.9%) |
| July 2017 | $7.09 M(-191.7%) | $199.40 K(-106.3%) | $7.09 M(+21.4%) |
| Apr 2017 | - | -$3.17 M(-129.8%) | $5.84 M(-38.0%) |
| Jan 2017 | - | $10.64 M(-1937.3%) | $9.42 M(+238.4%) |
| Oct 2016 | - | -$579.00 K(-44.9%) | $2.78 M(-136.0%) |
| July 2016 | -$7.74 M(+12.2%) | -$1.05 M(-355.1%) | -$7.74 M(-5.8%) |
| Apr 2016 | - | $411.90 K(-89.7%) | -$8.22 M(-21.5%) |
| Jan 2016 | - | $4.00 M(-136.0%) | -$10.47 M(-39.3%) |
| Oct 2015 | - | -$11.10 M(+626.2%) | -$17.24 M(+149.9%) |
| July 2015 | -$6.90 M(-39.0%) | -$1.53 M(-16.9%) | -$6.90 M(-27.3%) |
| Apr 2015 | - | -$1.84 M(-33.6%) | -$9.50 M(+15.8%) |
| Jan 2015 | - | -$2.77 M(+264.5%) | -$8.20 M(-22.1%) |
| Oct 2014 | - | -$760.10 K(-81.6%) | -$10.52 M(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2014 | -$11.30 M(+28.4%) | -$4.13 M(+654.4%) | -$11.30 M(+33.7%) |
| Apr 2014 | - | -$546.90 K(-89.3%) | -$8.46 M(-0.4%) |
| Jan 2014 | - | -$5.09 M(+230.7%) | -$8.49 M(-11.9%) |
| Oct 2013 | - | -$1.54 M(+20.4%) | -$9.64 M(+9.1%) |
| July 2013 | -$8.81 M(-28.6%) | -$1.28 M(+120.6%) | -$8.83 M(-3.6%) |
| Apr 2013 | - | -$579.60 K(-90.7%) | -$9.16 M(-8.7%) |
| Jan 2013 | - | -$6.24 M(+751.5%) | -$10.03 M(+19.9%) |
| Oct 2012 | - | -$733.00 K(-54.3%) | -$8.36 M(-32.2%) |
| July 2012 | -$12.34 M(+30.7%) | -$1.60 M(+10.5%) | -$12.34 M(-8.6%) |
| Apr 2012 | - | -$1.45 M(-68.3%) | -$13.49 M(-22.6%) |
| Jan 2012 | - | -$4.57 M(-2.8%) | -$17.44 M(+25.8%) |
| Oct 2011 | - | -$4.71 M(+70.5%) | -$13.86 M(+46.9%) |
| July 2011 | -$9.44 M(+367.9%) | -$2.76 M(-48.9%) | -$9.44 M(+31.8%) |
| Apr 2011 | - | -$5.40 M(+442.8%) | -$7.16 M(+261.9%) |
| Jan 2011 | - | -$994.70 K(+253.0%) | -$1.98 M(-11.0%) |
| Oct 2010 | - | -$281.80 K(-41.8%) | -$2.22 M(+10.2%) |
| July 2010 | -$2.02 M(>+9900.0%) | -$484.40 K(+122.8%) | -$2.02 M(+31.5%) |
| Apr 2010 | - | -$217.40 K(-82.5%) | -$1.53 M(+16.1%) |
| Jan 2010 | - | -$1.24 M(+1525.7%) | -$1.32 M(+1445.0%) |
| Oct 2009 | - | -$76.20 K(+4382.4%) | -$85.50 K(+481.6%) |
| July 2009 | -$14.70 K(-17.9%) | -$1700.00(-60.5%) | -$14.70 K(-41.2%) |
| Apr 2009 | - | -$4300.00(+30.3%) | -$25.00 K(+10.6%) |
| Jan 2009 | - | -$3300.00(-38.9%) | -$22.60 K(0.0%) |
| Oct 2008 | - | -$5400.00(-55.0%) | -$22.60 K(+26.3%) |
| July 2008 | -$17.90 K(-46.7%) | -$12.00 K(+531.6%) | -$17.90 K(-0.6%) |
| Apr 2008 | - | -$1900.00(-42.4%) | -$18.00 K(-15.1%) |
| Jan 2008 | - | -$3300.00(+371.4%) | -$21.20 K(+14.6%) |
| Oct 2007 | - | -$700.00(-94.2%) | -$18.50 K(-29.4%) |
| July 2007 | -$33.60 K | -$12.10 K(+137.3%) | -$26.20 K(+85.8%) |
| Apr 2007 | - | -$5100.00(+750.0%) | -$14.10 K(+48.4%) |
| Jan 2007 | - | -$600.00(-92.9%) | -$9500.00(+6.7%) |
| Oct 2006 | - | -$8400.00(+1580.0%) | -$8900.00(+1680.0%) |
| Apr 2006 | - | -$500.00(<-9900.0%) | -$500.00(<-9900.0%) |
| Jan 2006 | - | $0.00 | $0.00 |
FAQ
- What is Opiant Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual operating profit year-on-year change?
- What is Opiant Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly operating profit year-on-year change?
- What is Opiant Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals TTM operating profit year-on-year change?
What is Opiant Pharmaceuticals annual operaing income?
The current annual operating profit of OPNT is $5.16 M
What is the all time high annual operating profit for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual operaing income is $10.91 M
What is Opiant Pharmaceuticals annual operating profit year-on-year change?
Over the past year, OPNT annual operaing income has changed by +$7.40 M (+330.09%)
What is Opiant Pharmaceuticals quarterly operating income?
The current quarterly operating profit of OPNT is -$9.63 M
What is the all time high quarterly operating profit for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly operating income is $10.64 M
What is Opiant Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, OPNT quarterly operating income has changed by -$13.59 M (-343.15%)
What is Opiant Pharmaceuticals TTM operating income?
The current TTM operating profit of OPNT is -$31.51 M
What is the all time high TTM operating profit for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high TTM operating income is $11.02 M
What is Opiant Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, OPNT TTM operating income has changed by -$34.38 M (-1198.72%)